Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)

Motoko Yanagita; Satoru Muto; Hiroyuki Nishiyama; Yuichi Ando; Sumio Hirata; Kent Doi; Yutaka Fujiwara; Norio Hanafusa; Takahiro Hatta; Junichi Hoshino; Satoko Ichioka; Takamitsu Inoue; Kenji Ishikura; Taigo Kato; Hiroshi Kitamura; Yusuke Kobayashi; Yuichi Koizumi; Chihiro Kondoh; Takeshi Matsubara; Kazuo Matsubara; Koji Matsumoto; Yusuke Okuda; Yuta Okumura; Emiko Sakaida; Yugo Shibagaki; Hideki Shimodaira; Nao Takano; Akiko Uchida; Kimikazu Yakushijin; Takehito Yamamoto; Kazuhiro Yamamoto; Yoshinari Yasuda; Mototsugu Oya; Hirokazu Okada; Masaomi Nangaku; Naoki Kashihara

doi:10.1007/s10157-023-02436-9

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)

Motoko Yanagita^*, Satoru Muto, Hiroyuki Nishiyama, Yuichi Ando, Sumio Hirata, Kent Doi, Yutaka Fujiwara, Norio Hanafusa, Takahiro Hatta, Junichi Hoshino, Satoko Ichioka, Takamitsu Inoue, Kenji Ishikura, Taigo Kato, Hiroshi Kitamura, Yusuke Kobayashi, Yuichi Koizumi, Chihiro Kondoh, Takeshi Matsubara, Kazuo MatsubaraKoji Matsumoto, Yusuke Okuda, Yuta Okumura, Emiko Sakaida, Yugo Shibagaki, Hideki Shimodaira, Nao Takano, Akiko Uchida, Kimikazu Yakushijin, Takehito Yamamoto, Kazuhiro Yamamoto, Yoshinari Yasuda, Mototsugu Oya, Hirokazu Okada, Masaomi Nangaku, Naoki Kashihara

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the original publication, the abstract text has been inadvertently included in the article. We have removed the abstract text in the updated version. The original article has been corrected.

Original language	English
Pages (from-to)	123-124
Number of pages	2
Journal	Clinical and Experimental Nephrology
Volume	28
Issue number	2
DOIs	https://doi.org/10.1007/s10157-023-02436-9
State	Published - 2024/02

ASJC Scopus subject areas

Physiology
Nephrology
Physiology (medical)

Access to Document

10.1007/s10157-023-02436-9

Fingerprint

Dive into the research topics of 'Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)'. Together they form a unique fingerprint.

Cite this

Yanagita, M., Muto, S., Nishiyama, H., Ando, Y., Hirata, S., Doi, K., Fujiwara, Y., Hanafusa, N., Hatta, T., Hoshino, J., Ichioka, S., Inoue, T., Ishikura, K., Kato, T., Kitamura, H., Kobayashi, Y., Koizumi, Y., Kondoh, C., Matsubara, T., ... Kashihara, N. (2024). Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0). Clinical and Experimental Nephrology, 28(2), 123-124. https://doi.org/10.1007/s10157-023-02436-9

Yanagita, Motoko ; Muto, Satoru ; Nishiyama, Hiroyuki et al. / Correction to : Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0). In: Clinical and Experimental Nephrology. 2024 ; Vol. 28, No. 2. pp. 123-124.

@article{7489e1af3d00425ab555ab60d6f5f908,

title = "Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)",

abstract = "In the original publication, the abstract text has been inadvertently included in the article. We have removed the abstract text in the updated version. The original article has been corrected.",

author = "Motoko Yanagita and Satoru Muto and Hiroyuki Nishiyama and Yuichi Ando and Sumio Hirata and Kent Doi and Yutaka Fujiwara and Norio Hanafusa and Takahiro Hatta and Junichi Hoshino and Satoko Ichioka and Takamitsu Inoue and Kenji Ishikura and Taigo Kato and Hiroshi Kitamura and Yusuke Kobayashi and Yuichi Koizumi and Chihiro Kondoh and Takeshi Matsubara and Kazuo Matsubara and Koji Matsumoto and Yusuke Okuda and Yuta Okumura and Emiko Sakaida and Yugo Shibagaki and Hideki Shimodaira and Nao Takano and Akiko Uchida and Kimikazu Yakushijin and Takehito Yamamoto and Kazuhiro Yamamoto and Yoshinari Yasuda and Mototsugu Oya and Hirokazu Okada and Masaomi Nangaku and Naoki Kashihara",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Japanese Society of Nephrology.",

year = "2024",

month = feb,

doi = "10.1007/s10157-023-02436-9",

language = "英語",

volume = "28",

pages = "123--124",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer",

number = "2",

}

Yanagita, M, Muto, S, Nishiyama, H, Ando, Y, Hirata, S, Doi, K, Fujiwara, Y, Hanafusa, N, Hatta, T, Hoshino, J, Ichioka, S, Inoue, T, Ishikura, K, Kato, T, Kitamura, H, Kobayashi, Y, Koizumi, Y, Kondoh, C, Matsubara, T, Matsubara, K, Matsumoto, K, Okuda, Y, Okumura, Y, Sakaida, E, Shibagaki, Y, Shimodaira, H, Takano, N, Uchida, A, Yakushijin, K, Yamamoto, T, Yamamoto, K, Yasuda, Y, Oya, M, Okada, H, Nangaku, M & Kashihara, N 2024, 'Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)', Clinical and Experimental Nephrology, vol. 28, no. 2, pp. 123-124. https://doi.org/10.1007/s10157-023-02436-9

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0). / Yanagita, Motoko; Muto, Satoru; Nishiyama, Hiroyuki et al.
In: Clinical and Experimental Nephrology, Vol. 28, No. 2, 02.2024, p. 123-124.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0)

AU - Yanagita, Motoko

AU - Muto, Satoru

AU - Nishiyama, Hiroyuki

AU - Ando, Yuichi

AU - Hirata, Sumio

AU - Doi, Kent

AU - Fujiwara, Yutaka

AU - Hanafusa, Norio

AU - Hatta, Takahiro

AU - Hoshino, Junichi

AU - Ichioka, Satoko

AU - Inoue, Takamitsu

AU - Ishikura, Kenji

AU - Kato, Taigo

AU - Kitamura, Hiroshi

AU - Kobayashi, Yusuke

AU - Koizumi, Yuichi

AU - Kondoh, Chihiro

AU - Matsubara, Takeshi

AU - Matsubara, Kazuo

AU - Matsumoto, Koji

AU - Okuda, Yusuke

AU - Okumura, Yuta

AU - Sakaida, Emiko

AU - Shibagaki, Yugo

AU - Shimodaira, Hideki

AU - Takano, Nao

AU - Uchida, Akiko

AU - Yakushijin, Kimikazu

AU - Yamamoto, Takehito

AU - Yamamoto, Kazuhiro

AU - Yasuda, Yoshinari

AU - Oya, Mototsugu

AU - Okada, Hirokazu

AU - Nangaku, Masaomi

AU - Kashihara, Naoki

PY - 2024/2

Y1 - 2024/2

N2 - In the original publication, the abstract text has been inadvertently included in the article. We have removed the abstract text in the updated version. The original article has been corrected.

AB - In the original publication, the abstract text has been inadvertently included in the article. We have removed the abstract text in the updated version. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85178937959&partnerID=8YFLogxK

U2 - 10.1007/s10157-023-02436-9

DO - 10.1007/s10157-023-02436-9

M3 - コメント/討論

C2 - 38070021

AN - SCOPUS:85178937959

SN - 1342-1751

VL - 28

SP - 123

EP - 124

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

IS - 2

ER -

Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K et al. Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (Clinical and Experimental Nephrology, (2024), 28, 2, (85-122), 10.1007/s10157-023-02415-0). Clinical and Experimental Nephrology. 2024 Feb;28(2):123-124. doi: 10.1007/s10157-023-02436-9